http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105496949-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62a71b5ba45255cc0ee9ab38237e3a20
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383
filingDate 2015-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_473d1fedfa15e3c9cf07e0316d0b33b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8a1651882315d701dc0456afdf3d784
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0568ad5391ebfec8510de15abe771d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0794d9912b68a08238b4af3426700d9d
publicationDate 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105496949-A
titleOfInvention Preparation method of slow-released levofloxacin injection
abstract The invention provides a preparation method of a slow-released levofloxacin injection, and belongs to a slow-released injection for animals. The levofloxacin injection is prepared from, by weight, 5%-20% of levofloxacin, 1%-4% of fatty acid, 5%-35% of stabilizer and the balance organic solvent. The preparation method comprises the steps that levofloxacin and the organic solvent are taken and stirred for dissolution, the fatty acid is added to conduct a complexation reaction with a dissolved product, the stabilizer is added, after sufficient dissolution is achieved, the organic solvent is added for the scale volume, and the slow-released levofloxacin injection is obtained after membrane filtration is conducted. According to the preparation method of the slow-released levofloxacin injection, levofloxacin or a salt hydrate thereof is reacted with the fatty acid to form a new compound, the release time of levofloxacin can be prolonged, the effective blood drug concentration of a drug in an animal body can be maintained for a long time, and therefore the purposes of decreasing the frequency of drug delivery and reducing drug stress are achieved.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108567761-A
priorityDate 2015-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425321872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409982726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420591870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448013983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407378349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3229
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3893
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18373917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408813993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13296868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451518843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420229795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450067302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451679761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4678093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407698410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532884
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25119532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID525

Total number of triples: 64.